SlideShare a Scribd company logo
1 of 34
Download to read offline
RESPIRATORY ACIDOSIS AND ALKALOSIS…
Moderator/Resource Faculty: Dr. Deebya Raj Mishra…
Presented by: Nikhil Agarwal…
OBJECTIVES…
• Introduction
• Causes
• Diagnosis
• Management
INTRODUCTION…
• Respiratory acid-base disorders are those abnormalities in acid-base
equilibrium initiated by a change in the arterial carbon dioxide tension
(PaCO2 )--the respiratory determinant of acidity in the Henderson
equation:
H+= 24 x PaCO2 / [HCO3-]
• There are two respiratory acid-base disorders:
– respiratory acidosis and
– respiratory alkalosis.
RESPIRATORY ACIDOSIS…
• Respiratory acidosis is the acid-base disturbance initiated by an increase in
PaCO2.
• The level of PaCO2 is determined by the interaction of two factors, the rate
of carbon dioxide production (VCO2) and the rate of alveolar ventilation
(VA), as follows:
PaCO2 = K x VCO2 / VA
where K is a constant.
• An increase in arterial pCO2 can occur by one of three possible
mechanisms:
– Presence of excess CO2 in the inspired gas
– Decreased alveolar ventilation
– Increased production of CO2 by the body
• By far, most cases of respiratory acidosis reflect a
decrease in alveolar ventilation.
• Overproduction of carbon dioxide is usually
matched by increased excretion (due to increased
alveolar ventilation) such that hypercapnia
is prevented.
• Secondary physiologic response –
– Respiratory acidosis acidifies body fluids.
– It elicits adaptive increments in plasma bicarbonate concentration
that attenuate the impact of hypercapnia on systemic acidity; these
increments in plasma bicarbonate should be viewed as an integral
part of the respiratory acidosis.
RESPIRATORY ACIDOSIS…
• In acute respiratory acidosis, the PaCO2 is elevated above the
upper limit of the reference range (over 6.3 kPa or 45 mm Hg)
with an accompanying acidemia (pH <7.36). Acute respiratory
acidosis occurs when an abrupt failure of ventilation occurs.
• In chronic respiratory acidosis, the PaCO2 is elevated above the
upper limit of the reference range, with a normal blood pH
(7.35 to 7.45) or near-normal pH secondary to renal
compensation and an elevated serum bicarbonate (HCO3
−
>30 mm Hg).
ACUTE CAUSES…Normal airway and lungs Abnormal airway and lungs
Central nervous system depression
GA/ Sedative overdose
Head trauma/Cerebrovascular accident
Cerebral edema
Brain tumor/Encephalitis
Upper airway obstruction
Coma induced hypopharyngeal obstruction
Aspiration of foreign body or vomitus
Laryngospasm or angioedema
Obstructive sleep apnea
Neuromuscular impairment
High spinal cord injury, Guillain-Barre syndrome
Status epilepticus, Botulism, tetanus
Crisis in myathenia gravis
Hypokalemic myopathy
Drugs or toxic agents (curare, succinylcholine, aminoglycosides,
organophosphates)
Lower airway obstruction
Generalized bronchospasm
Severe asthma
Bronchiolitis of infants and adults
Ventilatory restriction
Rib fractures with flail chest
Pneumothorax, Hemothorax
Impaired diaphragmatic function
Disorders involving pulmonary alveoli
Severe bilateral pneumonia
Acute respiratory distress syndrome
Severe pulmonary edema
Iatrogenic events
Misplacement of airway cannula during mechanical ventilation
Bronchoscopy associated respiratory arrest
Increased CO2 production with constant mechanical
Ventilation
Pulmonary perfusion defect
Cardiac arrest, Severe circulatory failure
Massive pulmonary thromboembolism, Fat or air embolus
CHRONIC CAUSES…
Normal airway and lungs Abnormal airway and lungs
Central nervous system depression
Sedative overdose
Methadone/heroin addiction
Primary alveolar hypoventilation
Obesity-hypoventilation syndrome
Brain tumor
Bulbar poliomyelitis
Upper airway obstruction
Tonsillar and peritonsillar hypertrophy
Paralysis of vocal cords
Tumor of the cords or larynx
Airway stenosis post prolonged intubation
Thymoma, aortic aneurysm
Neuromuscular impairment
Poliomyelitis Multiple sclerosis
Muscular dystrophy
Amyotrophic lateral sclerosis
Diaphragmatic paralysis
Myxedema
Myopathic disease
Lower airway obstruction
Chronic obstructive lung disease (bronchitis, Bronchiolitis,
bronchiectasis, emphysema)
Ventilatory restriction
Kyphoscoliosis, spinal arthritis
Obesity
Fibrothorax Hydrothorax
Impaired diaphragmatic Function
Disorders involving pulmonary alveoli
Severe chronic pneumonitis
Diffuse infiltrative disease
Interstitial fibrosis
• 1. Acute adaptation
a. It is completed within 5-10 min from onset of hypercapnia.
b. It originates exclusively from acidic titration of the body’s
non-bicarbonate buffers (hemoglobin, intracellular proteins and
phosphates, plasma proteins):
CO2 + H2O ↔ H2CO3 ↔ HCO3
- + H+
H+ + Buf- ↔ HBuf
where Buf- refers to the base component and HBuf to the acid component of non-bicarbonate
buffers.
c. On average, plasma bicarbonate concentration increases by
about 0.1 mEq/L for each 1 mmHg acute increment in PaCO2; as a
result, plasma hydrogen ion concentration increases by about 0.75
nEq/L for each mm Hg acute rise in PaCO2.
• Chronic adaptation
a. It requires 3-5 days of sustained hypercapnia for completion.
b. It originates from up regulation of renal acidification mechanisms (both in the
proximal and distal segments of the nephron) that result in:
i. A transient increase in urinary net acid excretion; and
ii. A persistent increase in the rate of renal bicarbonate reabsorption that
maintains the increased plasma bicarbonate level.
c. On average, plasma HCO3
- concentration increases by about 0.3 mEq/L for each mm
Hg chronic increment in PaCO2; as a result, plasma H+ concentration increases by about 0.3
nEq/L for each mm Hg chronic rise in PaCO2.
Thus, at a given PaCO2 value, chronic adaptation provides better defense of systemic acidity
than acute adaptation.
d. The renal response to chronic hypercapnia includes a transient increase in chloride
excretion and generation of hypochloremia. This reduction in plasma chloride concentration
balances the increase in plasma bicarbonate concentration, plasma anion gap remaining
unchanged.
CLINICAL FEATURES…
• Varies according to the severity and duration of respiratory acidosis, the
underlying disease, and whether there is accompanying hypoxemia.
1. Neurological: “hypercapnic encephalopathy”include
1. irritability, inability to concentrate,
2. headache, anorexia,
3. apathy, confusion, combativeness, hallucinations, delirium,
4. transient psychosis, progressive narcosis, and coma.
5. Frank papilledema (pseudotumor cerebri) and motor disturbances (myoclonic
jerks, flapping tremor, and seizures).
The occurrence and severity of neurological manifestations depend on the
magnitude of hypercapnia, the rapidity with which it develops, the severity
of the acidemia, and the degree of the accompanying hypoxemia.
2. Cardiovascular: inhibition of myocardial contractility, direct
systemic vasodilation (especially in the cerebral circulation), but
also beta-adrenergic stimulation.
The effect in mild to moderate hypercapnia is usually increased cardiac output, normal
or increased blood pressure, and increased cerebral blood flow.
When hypercapnia is severe or considerable hypoxemia is present, decreases in both
cardiac output and blood pressure might be observed.
3. Renal: Salt and water retention often attends chronic
hypercapnia, especially in the presence of cor pulmonale.
3. In addition to the effects of heart failure on the kidney, contributing
factors include the stimulation of the beta-adrenergic system and the
renin-angiotensin-aldosterone axis, and the increased levels of anti-
diuretic hormone and cortisol.
DIAGNOSIS…
• Requires the measurement of PaCO2 and arterial pH (ABG analysis).
• A detailed history and physical examination may indicate the cause.
• Pulmonary function studies including spirometry, diffusion capacity
for CO, lung volumes and arterial PaCO2 and O2 saturation helps if
resp. acidosis is secondary to lung disease.
• For non-pulmonary causes, a detailed drug history, measurement
of hematocrit, and assessment of upper airway, chest wall, pleura
and neuromuscular function.
ARTERIAL FINDINGS IN RESP. ACIDOSIS…
• PCO2 is always raised.
• In acute respiratory failure.
– pH is low
– HCO3
- is high normal or slightly raised as compensatory changes take
sometimes to occur.
• In chronic respiratory failure.
– Ph is normal or low, depending on chronicity(time for compensation
to occur)
– HCO3
- is raised
MANAGEMENT…
• Primarily directed at the underlying disorder or patho-
physiologic process.
• Caution should be exercised in the correction of chronic
hypercapnia: too-rapid correction of the hypercapnia can result
in metabolic alkalemia.
• Alkalization of the cerebrospinal fluid (CSF) can result in
seizures.
Pharmacologic Therapy
• Pharmacologic therapies are generally used as treatment of the underlying
disease process.
• Bronchodilators: such as beta agonists (eg, albuterol and salmeterol),
anticholinergic agents (eg, ipratropium bromide and tiotropium), and
methylxanthines (eg, theophylline) are helpful in treating patients with
obstructive airway disease and severe bronchospasm. Theophylline may
improve diaphragm muscle contractility and may stimulate the respiratory
center.
• Drug antagonists: Drug therapy aimed at reversing the effects of certain
sedative drugs may be helpful in the event of an accidental or intentional
overdosage. Naloxone may be used to reverse the effects of narcotics.
Flumazenil may be used to reverse the effects of benzodiazepines.
• Respiratory stimulants: Respiratory stimulants have been used but
have limited efficacy in respiratory acidosis caused by disease.
– Medroxyprogesterone increases central respiratory drive and may be
effective in treating obesity-hypoventilation syndrome (OHS).
Medroxyprogesterone has also been shown to stimulate ventilation is
some patients with COPD and alveolar hypoventilation.
– Acetazolamide is a diuretic that increases bicarbonate excretion and
induces a metabolic acidosis, which subsequently stimulates ventilation.
– Theophylline increases diaphragm muscle strength and stimulates the
central ventilatory drive. In addition, theophylline is a bronchodilator.
• Oxygen Therapy
– Because many patients with hypercapnia are also hypoxemic, oxygen therapy may be
indicated.
– Oxygen therapy is employed to prevent the sequelae of long-standing hypoxemia.
– Hypercapnia is best avoided by titrating oxygen delivery to maintain oxygen saturation in
the low 90% range and partial arterial pressure of oxygen (PaO2) in the range of 60-65 mm
Hg.
• Ventilatory Support
– Therapeutic measures that may be lifesaving in severe hypercapnia and respiratory
acidosis include endotracheal intubation with mechanical ventilation and noninvasive
positive pressure ventilation (NIPPV)(they help improve PaO2 and decrease the PaCO2 )
techniques such as nasal continuous positive-pressure ventilation (NCPAP) and nasal
bilevel ventilation.
– Rapid correction of the hypercapnia by the application of external noninvasive positive-
pressure ventilation or invasive mechanical ventilation can result in alkalemia and the
development of sudden post- hypercapnic alkalosis with potential serious consequences.
Respiratory alkalosis…
• Respiratory alkalosis is the acid-base disturbance initiated by a reduction in
PaCO2.
• This occurs when there is excessive loss of CO2 by hyperventilation of
lungs.
• Hypocapnia develops when a sufficiently strong ventilatory stimulus causes
CO2 output in the lungs to exceed its metabolic production by the tissues.
• As a result, partial pressure of CO2 and H+ conc. falls and so there is a
decrease in bicarbonate levels.
Pathophysiology…
• By far, most cases of respiratory alkalosis reflect an increase in
alveolar ventilation.
• Primary decreases in CO2 production are generally attended by
parallel decreases in alveolar ventilation, thus preventing
expression of respiratory alkalosis.
• However, in the presence of constant alveolar ventilation (i.e.,
mechanical ventilation), decreased carbon dioxide production (e.g.,
sedation, skeletal muscle paralysis, hypothermia, hypothyroidism)
can cause respiratory alkalosis.
Secondary physiologic response
• Respiratory alkalosis alkalinizes body fluids. It elicits adaptive
decrements in plasma bicarbonate concentration that
attenuate the impact of hypocapnia on systemic acidity; these
decrements in plasma bicarbonate should be viewed as an
integral part of the respiratory alkalosis.
• Acute adaptation
a. It is completed within 5-10 min from onset of hypocapnia
b. It originates principally from alkaline titration of the body’s
nonbicarbonate buffers (hemoglobin, intracellular proteins and
phosphates, plasma proteins):
HBuf ↔ H+ + Buf-
HCO3
- + H+ ↔ H2CO3 ↔ H2O + CO2
where HBuf refers to the acid component and Buf- to the base component
ofnonbicarbonate buffers.
c. On average, plasma bicarbonate concentration falls by about
0.2 mEq/L for each mm Hg acute decrement in PaCO2; as a result,
plasma hydrogen ion concentration decreases by about 0.75 nEq/L
for each mm Hg acute reduction in PaCO2.
• Chronic adaptation
a. It requires 2-3 days of sustained hypocapnia for completion.
b. It originates from downregulation of renal acidification mechanisms (both in the
proximal and distal segments of the nephron) that result in
i. A transient decrease in urinary net acid excretion (mostly a fall in
ammonium excretion and an early component of increased bicarbonate excretion)
that reduces the body’s bicarbonate stores; and
ii. A persistent decrease in the rate of renal bicarbonate reabsorption that
maintains the decreased plasma bicarbonate level.
c. On average, plasma bicarbonate concentration decreases by about 0.4 mEq/L for
each mm Hg chronic decrement in PaCO2; as a result, plasma hydrogen ion concentration
decreases by about 0.4 nEq/L for each mm Hg chronic reduction in PaCO2. Thus, at a given
PaCO2 value, chronic adaptation provides better defense of systemic acidity than acute
adaptation.
d. Chronic hypocapnia is characterized by an increase in plasma chloride concentration
that balances most of the fall in plasma bicarbonate concentration, the remainder reflecting
a small increase in the plasma anion gap.
CAUSES…
Hypoxemia or tissue hypoxia
Decreased inspired O2 tension/High altitude
Bacterial or viral pneumonia
Aspiration of food, foreign body, or vomitus
Larygospasm, Drowning
Cyanotic heart disease, Severe ciurculatory failure
Severe anemia,Hypotension
Left shift deviation of HbO2 curve
Pulmonary embolism
Central nervous system stimulation
Voluntarily
Pain, Anxiety,
Psychosis, Fever
Subarachnoid hemorrhage
Cerebrovascular accident
Meningoencephalitis
Tumor, Trauma
Stimulation of chest receptors
Pneumonia, Asthma
Pneumothorax, Hemothorax, Flail chest
Infant or adult respiratory distress syndrome
Cardiac failure
Noncardiogenic pulmonary edema
Pulmonary embolism, Interstitial lung disease
Drugs or hormones
Nikethamide, ethamivan
Doxapram, Xanthines
Salicylates, Catecholamines
Angiotensin II, Vasopressor agents
Progesterone, Medroxyprogesterone
Dinitrophenol, Nicotine
Miscellaneous
Pregnancy, Sepsis, Hepatic failure
Mechanical hyperventilation
Heat exposure, Recovery form metabolic acidosis
CLINICAL FEATURES…
• Effects varies according to the severity and duration but are
primarily those of the underlying disease.
1. Neurological: Rapid decrements in PaCO2 to half the normal
values or lower are typically accompanied by
1. paresthesias of the extremities,
2. chest discomfort,
3. circumoral numbness, lightheadedness,
4. confusion, and infrequently, tetany or generalized seizures. These
manifestations are seldom present in the chronic phase.
Acute hypocapnia causes cerebral vasoconstriction and decreases
cerebral blood flow (in severe cases it can reach values less than
50% of normal) but flow essentially normalizes during sustained
hypocapnia.
2. Cardiovascular:
– No appreciable changes in cardiac output, systemic blood pressure, or
cardiac rhythm occur in actively hyperventilating subjects.
– However, major reductions in cardiac output and blood pressure, and
substantial hyperlactatemia frequently occur in passively hyperventilating
subjects (i.e., during mechanical ventilation) most likely reflecting the
decreased venous return associated with mechanical ventilation.
– In addition, patients with CAD might suffer hypocapnia-induced coronary
vasoconstriction, resulting in angina pectoris and arrhythmias.
Respiratory acidosis and alkalosis
DIAGNOSIS…
• Requires the measurement of PaCO2 and arterial pH.
• Plasma K + is often reduced and the Cl- is increased.
ARTERIAL FINDINGS IN RESP. ALKALOSIS…
• PCO2 is always reduced.
• HCO3
- is low normal or low.
• Ph is raised or normal.
TREATMENT…
• The treatment of respiratory alkalosis is primarily directed at correcting the underlying
disorder. Respiratory alkalosis itself is rarely life threatening.
• Therefore, emergent treatment is usually not indicated unless the pH level is greater than
7.5. Because respiratory alkalosis usually occurs in response to some stimulus, treatment is
usually unsuccessful unless the stimulus is controlled.
• If the PaCO2 is corrected rapidly in patients with chronic respiratory alkalosis, metabolic
acidosis may develop due to the renal compensatory drop in serum bicarbonate.
• In mechanically ventilated patients who have respiratory alkalosis, the tidal volume and/or
respiratory rate may need to be decreased. Inadequate sedation and pain control may
contribute to respiratory alkalosis in patients breathing over the set ventilator rate.
• In hyperventilation syndrome, patients benefit from reassurance,
rebreathing into a paper bag during acute episodes, and treatment
for underlying psychological stress.
• Sedatives and/or antidepressants should be reserved for patients
who have not responded to conservative treatment.
• Beta-adrenergic blockers may help control the manifestations of
the hyperadrenergic state that can lead to hyperventilation
syndrome in some patients
References :
• Longo, Fauci, Kasper et al Harrison’s principles of Internal Medicine, 18th Edition,
2012 (371-73)
• Aggarwal P., Matthew K.G., Medicine Prep Manual for Undergraduates, 4th Edition,
2014, (715-16)
• Alagappan R. Manual of Practical Medicine, 4th Edition, 2011, (424-26)
• Nicolaos Madias, MD: Tufts University School of Medicine
• Medscape
Respiratory acidosis and alkalosis

More Related Content

What's hot (20)

Metabolic acidosis
Metabolic acidosis Metabolic acidosis
Metabolic acidosis
 
Arterial Blood Gas (ABG) analysis
Arterial Blood Gas (ABG) analysisArterial Blood Gas (ABG) analysis
Arterial Blood Gas (ABG) analysis
 
Acidosis and alkalosis
Acidosis and alkalosisAcidosis and alkalosis
Acidosis and alkalosis
 
Acid base disorders
Acid base disordersAcid base disorders
Acid base disorders
 
Acid base balance
Acid base balance Acid base balance
Acid base balance
 
hypernatremia
hypernatremiahypernatremia
hypernatremia
 
Respiratory alkalosis and acidosis
Respiratory alkalosis and acidosisRespiratory alkalosis and acidosis
Respiratory alkalosis and acidosis
 
Diabetes ketoacidosis
Diabetes ketoacidosisDiabetes ketoacidosis
Diabetes ketoacidosis
 
ARTERIAL BLOOD GASES INTERPRETATION
ARTERIAL BLOOD GASES INTERPRETATIONARTERIAL BLOOD GASES INTERPRETATION
ARTERIAL BLOOD GASES INTERPRETATION
 
Acid base imbalances 2018
Acid  base imbalances 2018Acid  base imbalances 2018
Acid base imbalances 2018
 
Acid base Imbalance
Acid base ImbalanceAcid base Imbalance
Acid base Imbalance
 
ABG
ABGABG
ABG
 
Respiratory failure
Respiratory failureRespiratory failure
Respiratory failure
 
Metabolic alkalosis Dr. Mohamed Abdelhafez
Metabolic alkalosis Dr. Mohamed AbdelhafezMetabolic alkalosis Dr. Mohamed Abdelhafez
Metabolic alkalosis Dr. Mohamed Abdelhafez
 
Metabolic acidosis by akram
Metabolic acidosis by akramMetabolic acidosis by akram
Metabolic acidosis by akram
 
Respiratory failure
Respiratory failureRespiratory failure
Respiratory failure
 
Respiratory acidosis
Respiratory acidosisRespiratory acidosis
Respiratory acidosis
 
Arterial Blood Gases- ABG
Arterial Blood Gases- ABG Arterial Blood Gases- ABG
Arterial Blood Gases- ABG
 
Respiratory alkalosis
Respiratory alkalosisRespiratory alkalosis
Respiratory alkalosis
 
Diabetic Ketoacidosis
Diabetic KetoacidosisDiabetic Ketoacidosis
Diabetic Ketoacidosis
 

Viewers also liked

Acidosis and alkalosis
Acidosis and alkalosisAcidosis and alkalosis
Acidosis and alkalosisnahakul poudel
 
Metbolic acidosis and alkalosis
Metbolic acidosis and alkalosisMetbolic acidosis and alkalosis
Metbolic acidosis and alkalosisShrirang Rao
 
Metabolic acidosis
Metabolic acidosisMetabolic acidosis
Metabolic acidosissnich
 
Acid base disorders
Acid base disordersAcid base disorders
Acid base disordersqbank org
 
Acid-Base Disorders
Acid-Base DisordersAcid-Base Disorders
Acid-Base DisordersVitrag Shah
 
Regulation of Acid Base Balance
Regulation of Acid Base Balance Regulation of Acid Base Balance
Regulation of Acid Base Balance Abhirup Sarkar
 
Acute respiratory distress syndrome nursing care plan &amp; management
Acute respiratory distress syndrome nursing care plan &amp; managementAcute respiratory distress syndrome nursing care plan &amp; management
Acute respiratory distress syndrome nursing care plan &amp; managementNursing Path
 

Viewers also liked (8)

Acidosis and alkalosis
Acidosis and alkalosisAcidosis and alkalosis
Acidosis and alkalosis
 
Metbolic acidosis and alkalosis
Metbolic acidosis and alkalosisMetbolic acidosis and alkalosis
Metbolic acidosis and alkalosis
 
Acid base disorder
Acid base disorderAcid base disorder
Acid base disorder
 
Metabolic acidosis
Metabolic acidosisMetabolic acidosis
Metabolic acidosis
 
Acid base disorders
Acid base disordersAcid base disorders
Acid base disorders
 
Acid-Base Disorders
Acid-Base DisordersAcid-Base Disorders
Acid-Base Disorders
 
Regulation of Acid Base Balance
Regulation of Acid Base Balance Regulation of Acid Base Balance
Regulation of Acid Base Balance
 
Acute respiratory distress syndrome nursing care plan &amp; management
Acute respiratory distress syndrome nursing care plan &amp; managementAcute respiratory distress syndrome nursing care plan &amp; management
Acute respiratory distress syndrome nursing care plan &amp; management
 

Similar to Respiratory acidosis and alkalosis

Acid Base disorders.ppt
Acid Base disorders.pptAcid Base disorders.ppt
Acid Base disorders.pptssuser0622881
 
Acid Base Disturbances
Acid Base DisturbancesAcid Base Disturbances
Acid Base DisturbancesNayab Tariq
 
Arterial Blood Gas and Acid Base Balance
Arterial Blood Gas and Acid Base BalanceArterial Blood Gas and Acid Base Balance
Arterial Blood Gas and Acid Base BalanceDr Riham Hazem Raafat
 
Acute Respiratory Acidosis And Chronic Respirtory Acidosis
Acute Respiratory Acidosis And Chronic Respirtory AcidosisAcute Respiratory Acidosis And Chronic Respirtory Acidosis
Acute Respiratory Acidosis And Chronic Respirtory AcidosisLiz Brown
 
Respiratiory insufficiency
Respiratiory insufficiencyRespiratiory insufficiency
Respiratiory insufficiencyPrabita Shrestha
 
Approach to the poisoned patient part one
Approach to the poisoned patient part oneApproach to the poisoned patient part one
Approach to the poisoned patient part oneDomina Petric
 
ACID BASE DISORDERS 2.pptx
ACID BASE DISORDERS 2.pptxACID BASE DISORDERS 2.pptx
ACID BASE DISORDERS 2.pptxmusayansa
 
PRESENT: Acid base balance hossam (1).ppt
PRESENT: Acid base balance hossam (1).pptPRESENT: Acid base balance hossam (1).ppt
PRESENT: Acid base balance hossam (1).pptMbabazi Theos
 
Acute Respiratory failure.ppt
Acute Respiratory failure.pptAcute Respiratory failure.ppt
Acute Respiratory failure.pptCnetteSLumbo
 
ACUTE EXACERBATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
ACUTE EXACERBATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASEACUTE EXACERBATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
ACUTE EXACERBATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASEDr Dravid m c
 
Arterial blood gas (ABGs)
Arterial blood gas (ABGs)Arterial blood gas (ABGs)
Arterial blood gas (ABGs)Yamuna Sharma
 
Acute Respiratory Failure PPT.pptx
Acute Respiratory Failure PPT.pptxAcute Respiratory Failure PPT.pptx
Acute Respiratory Failure PPT.pptxJayBhanushali32
 
Cucchi acid base slides
Cucchi acid base slidesCucchi acid base slides
Cucchi acid base slidesChelsea Elise
 

Similar to Respiratory acidosis and alkalosis (20)

Acid Base disorders.ppt
Acid Base disorders.pptAcid Base disorders.ppt
Acid Base disorders.ppt
 
Acid Base Disturbances
Acid Base DisturbancesAcid Base Disturbances
Acid Base Disturbances
 
Acid base disorder
Acid base disorderAcid base disorder
Acid base disorder
 
Group 1
Group 1Group 1
Group 1
 
Acid and base balance
Acid and base balanceAcid and base balance
Acid and base balance
 
Hypercapnea &amp; hypocapnea (Physiology)
Hypercapnea &amp; hypocapnea (Physiology)Hypercapnea &amp; hypocapnea (Physiology)
Hypercapnea &amp; hypocapnea (Physiology)
 
Arterial Blood Gas and Acid Base Balance
Arterial Blood Gas and Acid Base BalanceArterial Blood Gas and Acid Base Balance
Arterial Blood Gas and Acid Base Balance
 
Acute Respiratory Acidosis And Chronic Respirtory Acidosis
Acute Respiratory Acidosis And Chronic Respirtory AcidosisAcute Respiratory Acidosis And Chronic Respirtory Acidosis
Acute Respiratory Acidosis And Chronic Respirtory Acidosis
 
Respiratiory insufficiency
Respiratiory insufficiencyRespiratiory insufficiency
Respiratiory insufficiency
 
Approach to the poisoned patient part one
Approach to the poisoned patient part oneApproach to the poisoned patient part one
Approach to the poisoned patient part one
 
ACID BASE DISORDERS 2.pptx
ACID BASE DISORDERS 2.pptxACID BASE DISORDERS 2.pptx
ACID BASE DISORDERS 2.pptx
 
PRESENT: Acid base balance hossam (1).ppt
PRESENT: Acid base balance hossam (1).pptPRESENT: Acid base balance hossam (1).ppt
PRESENT: Acid base balance hossam (1).ppt
 
Acute Respiratory failure.ppt
Acute Respiratory failure.pptAcute Respiratory failure.ppt
Acute Respiratory failure.ppt
 
ACUTE EXACERBATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
ACUTE EXACERBATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASEACUTE EXACERBATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
ACUTE EXACERBATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
 
Arterial blood gas (ABGs)
Arterial blood gas (ABGs)Arterial blood gas (ABGs)
Arterial blood gas (ABGs)
 
hypercarbia
 hypercarbia hypercarbia
hypercarbia
 
Acute Respiratory Failure PPT.pptx
Acute Respiratory Failure PPT.pptxAcute Respiratory Failure PPT.pptx
Acute Respiratory Failure PPT.pptx
 
Cucchi acid base slides
Cucchi acid base slidesCucchi acid base slides
Cucchi acid base slides
 
Acid base disorders
Acid base disordersAcid base disorders
Acid base disorders
 
Shock In Children
Shock In ChildrenShock In Children
Shock In Children
 

Recently uploaded

CELL BLOCK PREPARATION AND ITS IMPORTANCE
CELL BLOCK PREPARATION AND ITS IMPORTANCECELL BLOCK PREPARATION AND ITS IMPORTANCE
CELL BLOCK PREPARATION AND ITS IMPORTANCEShubhadip Ghosh
 
CANCER SeminarCancer Overview Type of Cancer.pptx
CANCER SeminarCancer Overview  Type of Cancer.pptxCANCER SeminarCancer Overview  Type of Cancer.pptx
CANCER SeminarCancer Overview Type of Cancer.pptxMrStavanUdayKadam
 
Spinal cord Gross anatomy with Clinical Anatomy.pptx
Spinal cord Gross anatomy with Clinical Anatomy.pptxSpinal cord Gross anatomy with Clinical Anatomy.pptx
Spinal cord Gross anatomy with Clinical Anatomy.pptxsiddharthroy26587
 
TARGET DELINEATION IN CERVIX CANCER BY DR KANHU
TARGET DELINEATION IN CERVIX CANCER BY DR KANHUTARGET DELINEATION IN CERVIX CANCER BY DR KANHU
TARGET DELINEATION IN CERVIX CANCER BY DR KANHUKanhu Charan
 
TARGET DELINEATION IN VULVAL CANCER BY DR KANHU
TARGET DELINEATION IN VULVAL CANCER BY DR KANHUTARGET DELINEATION IN VULVAL CANCER BY DR KANHU
TARGET DELINEATION IN VULVAL CANCER BY DR KANHUKanhu Charan
 
TARGET DELINEATION IN RECTUM CANCER BY DR KANHU
TARGET DELINEATION IN RECTUM  CANCER BY DR KANHUTARGET DELINEATION IN RECTUM  CANCER BY DR KANHU
TARGET DELINEATION IN RECTUM CANCER BY DR KANHUKanhu Charan
 
The Art and the Science of UK General Practice A historical review and timeli...
The Art and the Science of UK General Practice A historical review and timeli...The Art and the Science of UK General Practice A historical review and timeli...
The Art and the Science of UK General Practice A historical review and timeli...JakeMatthews12
 
HDT Unit 2: Nutraceuticals Global Market Overview And Growth Of Nutraceutical...
HDT Unit 2: Nutraceuticals Global Market Overview And Growth Of Nutraceutical...HDT Unit 2: Nutraceuticals Global Market Overview And Growth Of Nutraceutical...
HDT Unit 2: Nutraceuticals Global Market Overview And Growth Of Nutraceutical...Genesis Institute of Pharmacy, Radhanagari.
 
Basic of Thyroid Hormone:- An In-depth Analysis
Basic of Thyroid Hormone:- An In-depth AnalysisBasic of Thyroid Hormone:- An In-depth Analysis
Basic of Thyroid Hormone:- An In-depth AnalysisAshishMaletha2
 
Laryngeal papillomatosis .pdf ENT BY QUICKMEDTALK
Laryngeal papillomatosis .pdf ENT BY QUICKMEDTALKLaryngeal papillomatosis .pdf ENT BY QUICKMEDTALK
Laryngeal papillomatosis .pdf ENT BY QUICKMEDTALKQuick MedTalk
 
Cholesterol Biosynthesis and catabolism for MBBS, Lab. MEd. BDS.pptx
Cholesterol Biosynthesis  and catabolism for MBBS, Lab. MEd. BDS.pptxCholesterol Biosynthesis  and catabolism for MBBS, Lab. MEd. BDS.pptx
Cholesterol Biosynthesis and catabolism for MBBS, Lab. MEd. BDS.pptxRajendra Dev Bhatt
 
Substance use disorder (drug addict ), Addiction
Substance use disorder (drug addict ), AddictionSubstance use disorder (drug addict ), Addiction
Substance use disorder (drug addict ), AddictionZeinabEmad3
 
ANATOMY OF THE CEREBRUM WITH CLINICAL ANATOMY.pptx
ANATOMY OF THE CEREBRUM WITH CLINICAL ANATOMY.pptxANATOMY OF THE CEREBRUM WITH CLINICAL ANATOMY.pptx
ANATOMY OF THE CEREBRUM WITH CLINICAL ANATOMY.pptxsiddharthroy26587
 
Histology of lymph node(lymph node histology)
Histology of lymph node(lymph node histology)Histology of lymph node(lymph node histology)
Histology of lymph node(lymph node histology)pranavguleria2
 
HERPES SIMPLEX VIRUS 12032019 TUESDAY pptx
HERPES SIMPLEX VIRUS 12032019 TUESDAY  pptxHERPES SIMPLEX VIRUS 12032019 TUESDAY  pptx
HERPES SIMPLEX VIRUS 12032019 TUESDAY pptxPulkitMittal54
 
NECROSIS FOR MBBS FIRST YEAR STUDENTS MADE EASY.pptx
NECROSIS FOR MBBS FIRST YEAR STUDENTS MADE EASY.pptxNECROSIS FOR MBBS FIRST YEAR STUDENTS MADE EASY.pptx
NECROSIS FOR MBBS FIRST YEAR STUDENTS MADE EASY.pptxSizan Thapa
 
Ayurveda research in Hypothyroidism, P
Ayurveda  research  in Hypothyroidism, PAyurveda  research  in Hypothyroidism, P
Ayurveda research in Hypothyroidism, PDr.Shalu Jain
 
Ovarian tumors Lecture notes for MBBS.pptx
Ovarian tumors Lecture notes for MBBS.pptxOvarian tumors Lecture notes for MBBS.pptx
Ovarian tumors Lecture notes for MBBS.pptxSizan Thapa
 

Recently uploaded (20)

CELL BLOCK PREPARATION AND ITS IMPORTANCE
CELL BLOCK PREPARATION AND ITS IMPORTANCECELL BLOCK PREPARATION AND ITS IMPORTANCE
CELL BLOCK PREPARATION AND ITS IMPORTANCE
 
CANCER SeminarCancer Overview Type of Cancer.pptx
CANCER SeminarCancer Overview  Type of Cancer.pptxCANCER SeminarCancer Overview  Type of Cancer.pptx
CANCER SeminarCancer Overview Type of Cancer.pptx
 
Spinal cord Gross anatomy with Clinical Anatomy.pptx
Spinal cord Gross anatomy with Clinical Anatomy.pptxSpinal cord Gross anatomy with Clinical Anatomy.pptx
Spinal cord Gross anatomy with Clinical Anatomy.pptx
 
Oral disorders .pptx
Oral disorders .pptxOral disorders .pptx
Oral disorders .pptx
 
TARGET DELINEATION IN CERVIX CANCER BY DR KANHU
TARGET DELINEATION IN CERVIX CANCER BY DR KANHUTARGET DELINEATION IN CERVIX CANCER BY DR KANHU
TARGET DELINEATION IN CERVIX CANCER BY DR KANHU
 
TARGET DELINEATION IN VULVAL CANCER BY DR KANHU
TARGET DELINEATION IN VULVAL CANCER BY DR KANHUTARGET DELINEATION IN VULVAL CANCER BY DR KANHU
TARGET DELINEATION IN VULVAL CANCER BY DR KANHU
 
TARGET DELINEATION IN RECTUM CANCER BY DR KANHU
TARGET DELINEATION IN RECTUM  CANCER BY DR KANHUTARGET DELINEATION IN RECTUM  CANCER BY DR KANHU
TARGET DELINEATION IN RECTUM CANCER BY DR KANHU
 
Evolving Concepts in the Pathogenesis of Inflammatory Dermatologic Disorders ...
Evolving Concepts in the Pathogenesis of Inflammatory Dermatologic Disorders ...Evolving Concepts in the Pathogenesis of Inflammatory Dermatologic Disorders ...
Evolving Concepts in the Pathogenesis of Inflammatory Dermatologic Disorders ...
 
The Art and the Science of UK General Practice A historical review and timeli...
The Art and the Science of UK General Practice A historical review and timeli...The Art and the Science of UK General Practice A historical review and timeli...
The Art and the Science of UK General Practice A historical review and timeli...
 
HDT Unit 2: Nutraceuticals Global Market Overview And Growth Of Nutraceutical...
HDT Unit 2: Nutraceuticals Global Market Overview And Growth Of Nutraceutical...HDT Unit 2: Nutraceuticals Global Market Overview And Growth Of Nutraceutical...
HDT Unit 2: Nutraceuticals Global Market Overview And Growth Of Nutraceutical...
 
Basic of Thyroid Hormone:- An In-depth Analysis
Basic of Thyroid Hormone:- An In-depth AnalysisBasic of Thyroid Hormone:- An In-depth Analysis
Basic of Thyroid Hormone:- An In-depth Analysis
 
Laryngeal papillomatosis .pdf ENT BY QUICKMEDTALK
Laryngeal papillomatosis .pdf ENT BY QUICKMEDTALKLaryngeal papillomatosis .pdf ENT BY QUICKMEDTALK
Laryngeal papillomatosis .pdf ENT BY QUICKMEDTALK
 
Cholesterol Biosynthesis and catabolism for MBBS, Lab. MEd. BDS.pptx
Cholesterol Biosynthesis  and catabolism for MBBS, Lab. MEd. BDS.pptxCholesterol Biosynthesis  and catabolism for MBBS, Lab. MEd. BDS.pptx
Cholesterol Biosynthesis and catabolism for MBBS, Lab. MEd. BDS.pptx
 
Substance use disorder (drug addict ), Addiction
Substance use disorder (drug addict ), AddictionSubstance use disorder (drug addict ), Addiction
Substance use disorder (drug addict ), Addiction
 
ANATOMY OF THE CEREBRUM WITH CLINICAL ANATOMY.pptx
ANATOMY OF THE CEREBRUM WITH CLINICAL ANATOMY.pptxANATOMY OF THE CEREBRUM WITH CLINICAL ANATOMY.pptx
ANATOMY OF THE CEREBRUM WITH CLINICAL ANATOMY.pptx
 
Histology of lymph node(lymph node histology)
Histology of lymph node(lymph node histology)Histology of lymph node(lymph node histology)
Histology of lymph node(lymph node histology)
 
HERPES SIMPLEX VIRUS 12032019 TUESDAY pptx
HERPES SIMPLEX VIRUS 12032019 TUESDAY  pptxHERPES SIMPLEX VIRUS 12032019 TUESDAY  pptx
HERPES SIMPLEX VIRUS 12032019 TUESDAY pptx
 
NECROSIS FOR MBBS FIRST YEAR STUDENTS MADE EASY.pptx
NECROSIS FOR MBBS FIRST YEAR STUDENTS MADE EASY.pptxNECROSIS FOR MBBS FIRST YEAR STUDENTS MADE EASY.pptx
NECROSIS FOR MBBS FIRST YEAR STUDENTS MADE EASY.pptx
 
Ayurveda research in Hypothyroidism, P
Ayurveda  research  in Hypothyroidism, PAyurveda  research  in Hypothyroidism, P
Ayurveda research in Hypothyroidism, P
 
Ovarian tumors Lecture notes for MBBS.pptx
Ovarian tumors Lecture notes for MBBS.pptxOvarian tumors Lecture notes for MBBS.pptx
Ovarian tumors Lecture notes for MBBS.pptx
 

Respiratory acidosis and alkalosis

  • 1. RESPIRATORY ACIDOSIS AND ALKALOSIS… Moderator/Resource Faculty: Dr. Deebya Raj Mishra… Presented by: Nikhil Agarwal…
  • 3. INTRODUCTION… • Respiratory acid-base disorders are those abnormalities in acid-base equilibrium initiated by a change in the arterial carbon dioxide tension (PaCO2 )--the respiratory determinant of acidity in the Henderson equation: H+= 24 x PaCO2 / [HCO3-] • There are two respiratory acid-base disorders: – respiratory acidosis and – respiratory alkalosis.
  • 4. RESPIRATORY ACIDOSIS… • Respiratory acidosis is the acid-base disturbance initiated by an increase in PaCO2. • The level of PaCO2 is determined by the interaction of two factors, the rate of carbon dioxide production (VCO2) and the rate of alveolar ventilation (VA), as follows: PaCO2 = K x VCO2 / VA where K is a constant. • An increase in arterial pCO2 can occur by one of three possible mechanisms: – Presence of excess CO2 in the inspired gas – Decreased alveolar ventilation – Increased production of CO2 by the body
  • 5. • By far, most cases of respiratory acidosis reflect a decrease in alveolar ventilation. • Overproduction of carbon dioxide is usually matched by increased excretion (due to increased alveolar ventilation) such that hypercapnia is prevented.
  • 6. • Secondary physiologic response – – Respiratory acidosis acidifies body fluids. – It elicits adaptive increments in plasma bicarbonate concentration that attenuate the impact of hypercapnia on systemic acidity; these increments in plasma bicarbonate should be viewed as an integral part of the respiratory acidosis.
  • 7. RESPIRATORY ACIDOSIS… • In acute respiratory acidosis, the PaCO2 is elevated above the upper limit of the reference range (over 6.3 kPa or 45 mm Hg) with an accompanying acidemia (pH <7.36). Acute respiratory acidosis occurs when an abrupt failure of ventilation occurs. • In chronic respiratory acidosis, the PaCO2 is elevated above the upper limit of the reference range, with a normal blood pH (7.35 to 7.45) or near-normal pH secondary to renal compensation and an elevated serum bicarbonate (HCO3 − >30 mm Hg).
  • 8. ACUTE CAUSES…Normal airway and lungs Abnormal airway and lungs Central nervous system depression GA/ Sedative overdose Head trauma/Cerebrovascular accident Cerebral edema Brain tumor/Encephalitis Upper airway obstruction Coma induced hypopharyngeal obstruction Aspiration of foreign body or vomitus Laryngospasm or angioedema Obstructive sleep apnea Neuromuscular impairment High spinal cord injury, Guillain-Barre syndrome Status epilepticus, Botulism, tetanus Crisis in myathenia gravis Hypokalemic myopathy Drugs or toxic agents (curare, succinylcholine, aminoglycosides, organophosphates) Lower airway obstruction Generalized bronchospasm Severe asthma Bronchiolitis of infants and adults Ventilatory restriction Rib fractures with flail chest Pneumothorax, Hemothorax Impaired diaphragmatic function Disorders involving pulmonary alveoli Severe bilateral pneumonia Acute respiratory distress syndrome Severe pulmonary edema Iatrogenic events Misplacement of airway cannula during mechanical ventilation Bronchoscopy associated respiratory arrest Increased CO2 production with constant mechanical Ventilation Pulmonary perfusion defect Cardiac arrest, Severe circulatory failure Massive pulmonary thromboembolism, Fat or air embolus
  • 9. CHRONIC CAUSES… Normal airway and lungs Abnormal airway and lungs Central nervous system depression Sedative overdose Methadone/heroin addiction Primary alveolar hypoventilation Obesity-hypoventilation syndrome Brain tumor Bulbar poliomyelitis Upper airway obstruction Tonsillar and peritonsillar hypertrophy Paralysis of vocal cords Tumor of the cords or larynx Airway stenosis post prolonged intubation Thymoma, aortic aneurysm Neuromuscular impairment Poliomyelitis Multiple sclerosis Muscular dystrophy Amyotrophic lateral sclerosis Diaphragmatic paralysis Myxedema Myopathic disease Lower airway obstruction Chronic obstructive lung disease (bronchitis, Bronchiolitis, bronchiectasis, emphysema) Ventilatory restriction Kyphoscoliosis, spinal arthritis Obesity Fibrothorax Hydrothorax Impaired diaphragmatic Function Disorders involving pulmonary alveoli Severe chronic pneumonitis Diffuse infiltrative disease Interstitial fibrosis
  • 10. • 1. Acute adaptation a. It is completed within 5-10 min from onset of hypercapnia. b. It originates exclusively from acidic titration of the body’s non-bicarbonate buffers (hemoglobin, intracellular proteins and phosphates, plasma proteins): CO2 + H2O ↔ H2CO3 ↔ HCO3 - + H+ H+ + Buf- ↔ HBuf where Buf- refers to the base component and HBuf to the acid component of non-bicarbonate buffers. c. On average, plasma bicarbonate concentration increases by about 0.1 mEq/L for each 1 mmHg acute increment in PaCO2; as a result, plasma hydrogen ion concentration increases by about 0.75 nEq/L for each mm Hg acute rise in PaCO2.
  • 11. • Chronic adaptation a. It requires 3-5 days of sustained hypercapnia for completion. b. It originates from up regulation of renal acidification mechanisms (both in the proximal and distal segments of the nephron) that result in: i. A transient increase in urinary net acid excretion; and ii. A persistent increase in the rate of renal bicarbonate reabsorption that maintains the increased plasma bicarbonate level. c. On average, plasma HCO3 - concentration increases by about 0.3 mEq/L for each mm Hg chronic increment in PaCO2; as a result, plasma H+ concentration increases by about 0.3 nEq/L for each mm Hg chronic rise in PaCO2. Thus, at a given PaCO2 value, chronic adaptation provides better defense of systemic acidity than acute adaptation. d. The renal response to chronic hypercapnia includes a transient increase in chloride excretion and generation of hypochloremia. This reduction in plasma chloride concentration balances the increase in plasma bicarbonate concentration, plasma anion gap remaining unchanged.
  • 12. CLINICAL FEATURES… • Varies according to the severity and duration of respiratory acidosis, the underlying disease, and whether there is accompanying hypoxemia. 1. Neurological: “hypercapnic encephalopathy”include 1. irritability, inability to concentrate, 2. headache, anorexia, 3. apathy, confusion, combativeness, hallucinations, delirium, 4. transient psychosis, progressive narcosis, and coma. 5. Frank papilledema (pseudotumor cerebri) and motor disturbances (myoclonic jerks, flapping tremor, and seizures). The occurrence and severity of neurological manifestations depend on the magnitude of hypercapnia, the rapidity with which it develops, the severity of the acidemia, and the degree of the accompanying hypoxemia.
  • 13. 2. Cardiovascular: inhibition of myocardial contractility, direct systemic vasodilation (especially in the cerebral circulation), but also beta-adrenergic stimulation. The effect in mild to moderate hypercapnia is usually increased cardiac output, normal or increased blood pressure, and increased cerebral blood flow. When hypercapnia is severe or considerable hypoxemia is present, decreases in both cardiac output and blood pressure might be observed. 3. Renal: Salt and water retention often attends chronic hypercapnia, especially in the presence of cor pulmonale. 3. In addition to the effects of heart failure on the kidney, contributing factors include the stimulation of the beta-adrenergic system and the renin-angiotensin-aldosterone axis, and the increased levels of anti- diuretic hormone and cortisol.
  • 14. DIAGNOSIS… • Requires the measurement of PaCO2 and arterial pH (ABG analysis). • A detailed history and physical examination may indicate the cause. • Pulmonary function studies including spirometry, diffusion capacity for CO, lung volumes and arterial PaCO2 and O2 saturation helps if resp. acidosis is secondary to lung disease. • For non-pulmonary causes, a detailed drug history, measurement of hematocrit, and assessment of upper airway, chest wall, pleura and neuromuscular function.
  • 15. ARTERIAL FINDINGS IN RESP. ACIDOSIS… • PCO2 is always raised. • In acute respiratory failure. – pH is low – HCO3 - is high normal or slightly raised as compensatory changes take sometimes to occur. • In chronic respiratory failure. – Ph is normal or low, depending on chronicity(time for compensation to occur) – HCO3 - is raised
  • 16. MANAGEMENT… • Primarily directed at the underlying disorder or patho- physiologic process. • Caution should be exercised in the correction of chronic hypercapnia: too-rapid correction of the hypercapnia can result in metabolic alkalemia. • Alkalization of the cerebrospinal fluid (CSF) can result in seizures.
  • 17. Pharmacologic Therapy • Pharmacologic therapies are generally used as treatment of the underlying disease process. • Bronchodilators: such as beta agonists (eg, albuterol and salmeterol), anticholinergic agents (eg, ipratropium bromide and tiotropium), and methylxanthines (eg, theophylline) are helpful in treating patients with obstructive airway disease and severe bronchospasm. Theophylline may improve diaphragm muscle contractility and may stimulate the respiratory center. • Drug antagonists: Drug therapy aimed at reversing the effects of certain sedative drugs may be helpful in the event of an accidental or intentional overdosage. Naloxone may be used to reverse the effects of narcotics. Flumazenil may be used to reverse the effects of benzodiazepines.
  • 18. • Respiratory stimulants: Respiratory stimulants have been used but have limited efficacy in respiratory acidosis caused by disease. – Medroxyprogesterone increases central respiratory drive and may be effective in treating obesity-hypoventilation syndrome (OHS). Medroxyprogesterone has also been shown to stimulate ventilation is some patients with COPD and alveolar hypoventilation. – Acetazolamide is a diuretic that increases bicarbonate excretion and induces a metabolic acidosis, which subsequently stimulates ventilation. – Theophylline increases diaphragm muscle strength and stimulates the central ventilatory drive. In addition, theophylline is a bronchodilator.
  • 19. • Oxygen Therapy – Because many patients with hypercapnia are also hypoxemic, oxygen therapy may be indicated. – Oxygen therapy is employed to prevent the sequelae of long-standing hypoxemia. – Hypercapnia is best avoided by titrating oxygen delivery to maintain oxygen saturation in the low 90% range and partial arterial pressure of oxygen (PaO2) in the range of 60-65 mm Hg. • Ventilatory Support – Therapeutic measures that may be lifesaving in severe hypercapnia and respiratory acidosis include endotracheal intubation with mechanical ventilation and noninvasive positive pressure ventilation (NIPPV)(they help improve PaO2 and decrease the PaCO2 ) techniques such as nasal continuous positive-pressure ventilation (NCPAP) and nasal bilevel ventilation. – Rapid correction of the hypercapnia by the application of external noninvasive positive- pressure ventilation or invasive mechanical ventilation can result in alkalemia and the development of sudden post- hypercapnic alkalosis with potential serious consequences.
  • 20. Respiratory alkalosis… • Respiratory alkalosis is the acid-base disturbance initiated by a reduction in PaCO2. • This occurs when there is excessive loss of CO2 by hyperventilation of lungs. • Hypocapnia develops when a sufficiently strong ventilatory stimulus causes CO2 output in the lungs to exceed its metabolic production by the tissues. • As a result, partial pressure of CO2 and H+ conc. falls and so there is a decrease in bicarbonate levels.
  • 21. Pathophysiology… • By far, most cases of respiratory alkalosis reflect an increase in alveolar ventilation. • Primary decreases in CO2 production are generally attended by parallel decreases in alveolar ventilation, thus preventing expression of respiratory alkalosis. • However, in the presence of constant alveolar ventilation (i.e., mechanical ventilation), decreased carbon dioxide production (e.g., sedation, skeletal muscle paralysis, hypothermia, hypothyroidism) can cause respiratory alkalosis.
  • 22. Secondary physiologic response • Respiratory alkalosis alkalinizes body fluids. It elicits adaptive decrements in plasma bicarbonate concentration that attenuate the impact of hypocapnia on systemic acidity; these decrements in plasma bicarbonate should be viewed as an integral part of the respiratory alkalosis.
  • 23. • Acute adaptation a. It is completed within 5-10 min from onset of hypocapnia b. It originates principally from alkaline titration of the body’s nonbicarbonate buffers (hemoglobin, intracellular proteins and phosphates, plasma proteins): HBuf ↔ H+ + Buf- HCO3 - + H+ ↔ H2CO3 ↔ H2O + CO2 where HBuf refers to the acid component and Buf- to the base component ofnonbicarbonate buffers. c. On average, plasma bicarbonate concentration falls by about 0.2 mEq/L for each mm Hg acute decrement in PaCO2; as a result, plasma hydrogen ion concentration decreases by about 0.75 nEq/L for each mm Hg acute reduction in PaCO2.
  • 24. • Chronic adaptation a. It requires 2-3 days of sustained hypocapnia for completion. b. It originates from downregulation of renal acidification mechanisms (both in the proximal and distal segments of the nephron) that result in i. A transient decrease in urinary net acid excretion (mostly a fall in ammonium excretion and an early component of increased bicarbonate excretion) that reduces the body’s bicarbonate stores; and ii. A persistent decrease in the rate of renal bicarbonate reabsorption that maintains the decreased plasma bicarbonate level. c. On average, plasma bicarbonate concentration decreases by about 0.4 mEq/L for each mm Hg chronic decrement in PaCO2; as a result, plasma hydrogen ion concentration decreases by about 0.4 nEq/L for each mm Hg chronic reduction in PaCO2. Thus, at a given PaCO2 value, chronic adaptation provides better defense of systemic acidity than acute adaptation. d. Chronic hypocapnia is characterized by an increase in plasma chloride concentration that balances most of the fall in plasma bicarbonate concentration, the remainder reflecting a small increase in the plasma anion gap.
  • 25. CAUSES… Hypoxemia or tissue hypoxia Decreased inspired O2 tension/High altitude Bacterial or viral pneumonia Aspiration of food, foreign body, or vomitus Larygospasm, Drowning Cyanotic heart disease, Severe ciurculatory failure Severe anemia,Hypotension Left shift deviation of HbO2 curve Pulmonary embolism Central nervous system stimulation Voluntarily Pain, Anxiety, Psychosis, Fever Subarachnoid hemorrhage Cerebrovascular accident Meningoencephalitis Tumor, Trauma Stimulation of chest receptors Pneumonia, Asthma Pneumothorax, Hemothorax, Flail chest Infant or adult respiratory distress syndrome Cardiac failure Noncardiogenic pulmonary edema Pulmonary embolism, Interstitial lung disease Drugs or hormones Nikethamide, ethamivan Doxapram, Xanthines Salicylates, Catecholamines Angiotensin II, Vasopressor agents Progesterone, Medroxyprogesterone Dinitrophenol, Nicotine Miscellaneous Pregnancy, Sepsis, Hepatic failure Mechanical hyperventilation Heat exposure, Recovery form metabolic acidosis
  • 26. CLINICAL FEATURES… • Effects varies according to the severity and duration but are primarily those of the underlying disease. 1. Neurological: Rapid decrements in PaCO2 to half the normal values or lower are typically accompanied by 1. paresthesias of the extremities, 2. chest discomfort, 3. circumoral numbness, lightheadedness, 4. confusion, and infrequently, tetany or generalized seizures. These manifestations are seldom present in the chronic phase. Acute hypocapnia causes cerebral vasoconstriction and decreases cerebral blood flow (in severe cases it can reach values less than 50% of normal) but flow essentially normalizes during sustained hypocapnia.
  • 27. 2. Cardiovascular: – No appreciable changes in cardiac output, systemic blood pressure, or cardiac rhythm occur in actively hyperventilating subjects. – However, major reductions in cardiac output and blood pressure, and substantial hyperlactatemia frequently occur in passively hyperventilating subjects (i.e., during mechanical ventilation) most likely reflecting the decreased venous return associated with mechanical ventilation. – In addition, patients with CAD might suffer hypocapnia-induced coronary vasoconstriction, resulting in angina pectoris and arrhythmias.
  • 29. DIAGNOSIS… • Requires the measurement of PaCO2 and arterial pH. • Plasma K + is often reduced and the Cl- is increased.
  • 30. ARTERIAL FINDINGS IN RESP. ALKALOSIS… • PCO2 is always reduced. • HCO3 - is low normal or low. • Ph is raised or normal.
  • 31. TREATMENT… • The treatment of respiratory alkalosis is primarily directed at correcting the underlying disorder. Respiratory alkalosis itself is rarely life threatening. • Therefore, emergent treatment is usually not indicated unless the pH level is greater than 7.5. Because respiratory alkalosis usually occurs in response to some stimulus, treatment is usually unsuccessful unless the stimulus is controlled. • If the PaCO2 is corrected rapidly in patients with chronic respiratory alkalosis, metabolic acidosis may develop due to the renal compensatory drop in serum bicarbonate. • In mechanically ventilated patients who have respiratory alkalosis, the tidal volume and/or respiratory rate may need to be decreased. Inadequate sedation and pain control may contribute to respiratory alkalosis in patients breathing over the set ventilator rate.
  • 32. • In hyperventilation syndrome, patients benefit from reassurance, rebreathing into a paper bag during acute episodes, and treatment for underlying psychological stress. • Sedatives and/or antidepressants should be reserved for patients who have not responded to conservative treatment. • Beta-adrenergic blockers may help control the manifestations of the hyperadrenergic state that can lead to hyperventilation syndrome in some patients
  • 33. References : • Longo, Fauci, Kasper et al Harrison’s principles of Internal Medicine, 18th Edition, 2012 (371-73) • Aggarwal P., Matthew K.G., Medicine Prep Manual for Undergraduates, 4th Edition, 2014, (715-16) • Alagappan R. Manual of Practical Medicine, 4th Edition, 2011, (424-26) • Nicolaos Madias, MD: Tufts University School of Medicine • Medscape

Editor's Notes

  1. where PAO2 is alveolar oxygen tension. Thus, in the absence of supplemental oxygen, it is not possible for PaCO2 to reach values much higher than 80 mm Hg while the level of PaO2, the arterial oxygen tension, is still compatible with life. Extreme hypercapnia can only be seen in subjects receiving oxygen supplementation.
  2. Management of respiratory alkalosis must be directed toward correcting the underlying cause, whenever possible. A notable exception is the patient with the anxiety-hyperventilation syndrome; in addition to reassurance or sedation, rebreathing into a closed system (e.g., a paper bag) might prove helpful by interrupting the vicious cycle that can result from the reinforcing effects of the symptoms of hypocapnia. Administration of acetazolamide can be beneficial in the management of signs and symptoms of high-altitude sickness, a syndrome characterized by hypoxemia and respiratory alkalosis. Considering the risks of severe alkalemia, sedation or, in rare instances, skeletal muscle paralysis and mechanical ventilation might be required to temporarily correct marked respiratory alkalosis. Of course, patients undergoing mechanical ventilation lend themselves to an effective correction of hypocapnia (whether due to maladjusted ventilator or other causes) by resetting the device or increasing the dead space of the system.